| Exosome Delivered Anticancer Drugs Across the Blood-Brain Barrier for Brain Cancer Therapy in Danio Rerio T Yang, P Martin, B Fogarty, A Brown, K Schurman, R Phipps, VP Yin, ... Pharmaceutical research 32, 2003-2014, 2015 | 941 | 2015 |
| Nanoparticle surface charges alter blood–brain barrier integrity and permeability PR Lockman, JM Koziara, RJ Mumper, DD Allen Journal of drug targeting 12 (9-10), 635-641, 2004 | 859 | 2004 |
| Nanoparticle technology for drug delivery across the blood-brain barrier PR Lockman, RJ Mumper, MA Khan, DD Allen Drug development and industrial pharmacy 28 (1), 1-13, 2002 | 797 | 2002 |
| Heterogeneous blood–tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer PR Lockman, RK Mittapalli, KS Taskar, V Rudraraju, B Gril, KA Bohn, ... Clinical cancer research 16 (23), 5664-5678, 2010 | 677 | 2010 |
| Paclitaxel nanoparticles for the potential treatment of brain tumors JM Koziara, PR Lockman, DD Allen, RJ Mumper Journal of controlled release 99 (2), 259-269, 2004 | 404 | 2004 |
| Brain uptake of thiamine-coated nanoparticles PR Lockman, MO Oyewumi, JM Koziara, KE Roder, RJ Mumper, DD Allen Journal of controlled release 93 (3), 271-282, 2003 | 346 | 2003 |
| In Situ Blood–Brain Barrier Transport of Nanoparticles JM Koziara, PR Lockman, DD Allen, RJ Mumper Pharmaceutical research 20, 1772-1778, 2003 | 272 | 2003 |
| Uptake of ANG1005, a novel paclitaxel derivative, through the blood-brain barrier into brain and experimental brain metastases of breast cancer FC Thomas, K Taskar, V Rudraraju, S Goda, HR Thorsheim, JA Gaasch, ... Pharmaceutical research 26, 2486-2494, 2009 | 262 | 2009 |
| Novel D-penicillamine carrying nanoparticles for metal chelation therapy in Alzheimer's and other CNS diseases Z Cui, PR Lockman, CS Atwood, CH Hsu, A Gupte, DD Allen, RJ Mumper European journal of pharmaceutics and biopharmaceutics 59 (2), 263-272, 2005 | 259 | 2005 |
| Brain iron toxicity: differential responses of astrocytes, neurons, and endothelial cells JA Gaasch, PR Lockman, WJ Geldenhuys, DD Allen, CJ Van der Schyf Neurochemical research 32, 1196-1208, 2007 | 250 | 2007 |
| Lapatinib distribution in HER2 overexpressing experimental brain metastases of breast cancer KS Taskar, V Rudraraju, RK Mittapalli, R Samala, HR Thorsheim, ... Pharmaceutical research 29, 770-781, 2012 | 228 | 2012 |
| The transport of choline PR Lockman, DD Allen Drug development and industrial pharmacy 28 (7), 749-771, 2002 | 213 | 2002 |
| Vorinostat inhibits brain metastatic colonization in a model of triple-negative breast cancer and induces DNA double-strand breaks D Palmieri, PR Lockman, FC Thomas, E Hua, J Herring, E Hargrave, ... Clinical Cancer Research 15 (19), 6148-6157, 2009 | 176 | 2009 |
| Capecitabine and lapatinib uptake in surgically resected brain metastases from metastatic breast cancer patients: a prospective study A Morikawa, DM Peereboom, HR Thorsheim, R Samala, R Balyan, ... Neuro-oncology 17 (2), 289-295, 2015 | 166 | 2015 |
| Alterations in pericyte subpopulations are associated with elevated blood–tumor barrier permeability in experimental brain metastasis of breast cancer LT Lyle, PR Lockman, CE Adkins, AS Mohammad, E Sechrest, E Hua, ... Clinical Cancer Research 22 (21), 5287-5299, 2016 | 159 | 2016 |
| Combating Alzheimer's disease with multifunctional molecules designed for metal passivation H Schugar, DE Green, ML Bowen, LE Scott, T Storr, K Böhmerle, ... Angewandte Chemie 119 (10), 1746-1748, 2007 | 154 | 2007 |
| In Vivo and in Vitro Assessment of Baseline Blood-Brain Barrier Parameters in the Presence of Novel Nanoparticles PR Lockman, J Koziara, KE Roder, J Paulson, TJ Abbruscato, RJ Mumper, ... Pharmaceutical research 20, 705-713, 2003 | 138 | 2003 |
| The blood-brain barrier and brain drug delivery JM Koziara, PR Lockman, DD Allen, RJ Mumper Journal of nanoscience and nanotechnology 6 (9-10), 2712-2735, 2006 | 133 | 2006 |
| Investigational chemotherapy and novel pharmacokinetic mechanisms for the treatment of breast cancer brain metastases N Shah, AS Mohammad, P Saralkar, SA Sprowls, SD Vickers, D John, ... Pharmacological research 132, 47-68, 2018 | 123 | 2018 |
| Molecular determinants of blood–brain barrier permeation WJ Geldenhuys, AS Mohammad, CE Adkins, PR Lockman Therapeutic delivery 6 (8), 961-971, 2015 | 119 | 2015 |
Rajendar K MittapalliClinical Pharmacology Lead, Pfizer Inc.Verified email at pfizer.com
